Osteoid osteoma: Difference between revisions
Line 191: | Line 191: | ||
===Electrocardiogram=== | ===Electrocardiogram=== | ||
There are no ECG findings associated with osteoid osteoma. | * There are no ECG findings associated with osteoid osteoma. | ||
===X-ray=== | ===X-ray=== |
Revision as of 17:42, 18 December 2018
For patient information click here
For more information about osteoma that is not associated with osteoid osteoma, see osteoma
Template:Osteoid osteoma
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Synonyms and keywords: Osteoma osteoid; OO; Osteoid osteomas
Overview
Historical Perspective
- In 1930, Dr. Bergstrand, a German physician, first described osteoid osteoma in 1930.[1]
- In 1935, Dr.Henry Jaffe, an American pathologist first described osteoid osteoma as a benign bone tumor.[2]
- In 1953, Dr. Jaffe coined the term nidus, which was described as the “core”, referring to the tumor itself and is composed of bone at various stages of maturity within a highly vascular connective tissue stroma.[3]
- In 1954, Dahlin and Johnson added the term giant osteoid osteomas.[4]
- In 1966, Dr.Edeiken classifed osteoid osteomas into three types.[2]
Classification
- Osteoid Osteoma can be classified based on location and imaging findings.
Anatomical Classification
Type of osteoid osteoma | Characteristics |
---|---|
Intracortical | Dense sclerosis around the nidus |
Periosteal | Periosteal reaction |
Cancellous (medullary) | Produces very little reactive bone |
Subarticular | Simulates arthritis as it produces synovial reactions |
Enneking (MSTS) Staging System
- The Enneking surgical staging system (also known as the MSTS system) for benign musculoskeletal tumors based on radiographic characteristics of the tumor host margin.[7]
- It is widely accepted and routinely used classification.
Stages | Description |
---|---|
1 | Latent: Well demarcated borders |
2 | Active: Indistinct borders |
3 | Aggressive: Indistinct borders |
Pathophysiology
- The exact etiology of osteoid osteoma is unknown.[8]
- Osteoid osteoma arises from the osteoblasts.
- Osteoid osteoma consists of radially oriented trabeculae of surrounding reactive bone, indicating an increased pressure in the vascular nidus.
- This arrangement of the bony trabeculae is due to the stresses placed on them.
- This increased pressure is due to vasodilatation and edema is which stimulate intraosseous nerve endings, generating pain.[9]
- In addiition, the pain is also attributed to increased local concentration of prostaglandin E2, COX1 & 2 expression; and increased number and size of unmyelinated nerve fibers within the nidus.
- Osteoid osteomas are usually cortical lesions but they can occur anywhere within the bone including medullary, subperiosteal (most common in talus), and intracapsular area.
- More than 50 percent of osteoid osteomas occur in lower extremity of long bones.[2][10]
- It most commonly affects the metadiaphysis of the femur and tibia.
- About 20 percent of osteoid osteomas occur in the posterior elements of the spine.
Genetics
- The structural chromosomal alterations involving 22q13.1 in osteoid osteoma may affect critical genes involved in the regulation of cell proliferation, such as the YWHAH gene.[11]
- YWHAH gene codes for a 14-3-3 family members of dimeric phosphoserine-binding proteins that participate in signal transduction and checkpoint control pathways.
- Their primary function is to inhibit apoptosis.
- Another gene mapped in this region is PDGFB that codes for a platelet-derived growth factor, a beta polypeptide (simian sarcoma viral [v-sis] oncogene homolog), a potent mitogen for cells of mesenchymal origin and involved in the transformation process.
Causes
- The cause of osteoid osteoma has not been identified.[12]
Differentiating ((Page name)) from Other Diseases
- Osteoid osteoma must be differentiated from other diseases that cause night-pain, soft tissue swelling, and bowing deformity such as other osteogenic tumors, osteoblastoma, bone abscess (Brodie abscess), osteosarcoma, and enostosis.[13][14]
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Osteoblastoma |
|
|
Brodie abscess |
|
|
Osteosarcoma |
|
|
Enostosis |
|
|
Epidemiology and Demographics
- Osteoid osteoma is the third most common benign bone tumor.[15][16]
- Its incidence is 11% among the benign tumors and 3% among all primary bone tumors.[17]
- Adolescents and children are most affected by osteoid osteoma.
- The age distribution of osteoid osteoma is between 5-22 years.[18]
- The mean age of the patients with osteoid osteoma is 12 years (range, 8-35 years).[18]
- Men are more commonly affected than women, with a 6:4 ratio.[18]
- There is no racial predilection to osteoid osteoma.
Risk Factors
There are no established risk factors for osteoid osteoma.[19]
Screening
- There is insufficient evidence to recommend routine screening for osteoid osteoma.
Natural History, Complications, and Prognosis
- The natural history of untreated osteoid osteoma is toward spontaneous regression, it is taken an average of 6 years.[20]
- During this period, the nidus gradually begins to calcify; afterwards, ossify, and, finally, blends into sclerotic surrounding bone.
- The local pain gradually diminishes over time.
- Common complications of osteoid osteoma includes pathological fracture, stress fracture, and muscle atrophy.
- Prognosis is generally excellent after surgery.
- Local recurrence is rare but may occur 6 months after surgery.
Diagnosis
Diagnostic Study of Choice
- Biopsy is the diagnostic study of choice for the diagnosis of osteoid osteoma.
- Biopsy demonstrates the following features:
- Nidus usually about 1.5-2cms, brownish-red, mottled, and gritty lesion that is distinct from the surrounding bone.
- Network of interconnecting bone, widened vessels, osteoblasts, and bone matrix
- Fibrinoid margin with areas of angiogenesis
- Adjacent sclerosis
- On histological examination:
- Osteoid and woven bone lined with osteoblasts and richly innervated with surrounding hypervascular connective tissue with osteoclasts is seen.
- Osteoid osteoma do not malignantly transform.
History and Symptoms
- The majority of patients with osteoid osteoma have localized pain that worsens at night.[21]
- The pain is relieved by salicylates.
- Swelling
- Intra-articular lesions present with:
- Limb deformity
- Abnormal gait
- Lesions invloving spine present as back pain.
Physical Examination
- Patients with osteoid osteoma usually appears well.
- Common physical examination findings of osteoblastoma include:[22]
- Palpable bone deformity
- swelling
- Erythema
- Tenderness
- If the lesion is in proximity to a joint, findings include:
- Effusion
- Contracture
- Abnormal gait
- Muscle atrophy
- If the lesion involves spine, findings include:
- Postural scoliosis
- Paravertebral muscle spasm
Laboratory Findings
- There are no diagnostic laboratory findings associated with osteoid osteoma.
Electrocardiogram
- There are no ECG findings associated with osteoid osteoma.
X-ray
There are no x-ray findings associated with [disease name].
OR
An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
Echocardiography or Ultrasound
There are no echocardiography/ultrasound findings associated with [disease name].
OR
Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
CT scan
There are no CT scan findings associated with [disease name].
OR
[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
MRI
There are no MRI findings associated with [disease name].
OR
[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
Other Imaging Findings
There are no other imaging findings associated with [disease name].
OR
[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
There are no other diagnostic studies associated with [disease name].
OR
[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].
Treatment
Medical Therapy
There is no treatment for [disease name]; the mainstay of therapy is supportive care.
OR
Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].
OR
The majority of cases of [disease name] are self-limited and require only supportive care.
OR
[Disease name] is a medical emergency and requires prompt treatment.
OR
The mainstay of treatment for [disease name] is [therapy].
OR The optimal therapy for [malignancy name] depends on the stage at diagnosis.
OR
[Therapy] is recommended among all patients who develop [disease name].
OR
Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
OR
Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
OR
Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
OR
Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].
Surgery
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Primary Prevention
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
References
- ↑ Karandikar S, Thakur G, Tijare M, Shreenivas K, Agrawal K (2011). "Osteoid osteoma of mandible". BMJ Case Rep. 2011. doi:10.1136/bcr.10.2011.4886. PMC 3233922. PMID 22669768.
- ↑ 2.0 2.1 2.2 Torg JS, Loughran T, Pavlov H, Schwamm H, Gregg J, Sherman M, Balduini FC (1985). "Osteoid osteoma. Distant, periarticular, and subarticular lesions as a cause of knee pain". Sports Med. 2 (4): 296–304. PMID 3849059.
- ↑ Chai JW, Hong SH, Choi JY, Koh YH, Lee JW, Choi JA; et al. (2010). "Radiologic diagnosis of osteoid osteoma: from simple to challenging findings". Radiographics. 30 (3): 737–49. doi:10.1148/rg.303095120. PMID 20462991.
- ↑ DAHLIN DC, JOHNSON EW (1954). "Giant osteoid osteoma". J Bone Joint Surg Am. 36-A (3): 559–72. PMID 13163088.
- ↑ Morton KS, Vassar PS, Knickerbocker WJ (1975). "Osteoid osteoma and osteoblastoma: reclassification of 43 cases using Schajowicz's classification". Can J Surg. 18 (2): 148–52. PMID 1116053.
- ↑ Hakim DN, Pelly T, Kulendran M, Caris JA (2015). "Benign tumours of the bone: A review". J Bone Oncol. 4 (2): 37–41. doi:10.1016/j.jbo.2015.02.001. PMC 4620948. PMID 26579486.
- ↑ Jawad MU, Scully SP (2010). "In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system". Clin Orthop Relat Res. 468 (7): 2000–2. doi:10.1007/s11999-010-1315-7. PMC 2882012. PMID 20333492.
- ↑ Athwal P, Stock H (2014). "Osteoid osteoma: a pictorial review". Conn Med. 78 (4): 233–5. PMID 24830123.
- ↑ O'Connell JX, Nanthakumar SS, Nielsen GP, Rosenberg AE (1998). "Osteoid osteoma: the uniquely innervated bone tumor". Mod. Pathol. 11 (2): 175–80. PMID 9504688.
- ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.
- ↑ Baruffi MR, Volpon JB, Neto JB, Casartelli C (2001). "Osteoid osteomas with chromosome alterations involving 22q". Cancer Genet Cytogenet. 124 (2): 127–31. PMID 11172903.
- ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.
- ↑ Hashemi J, Gharahdaghi M, Ansaripour E, Jedi F, Hashemi S (2011). "Radiological features of osteoid osteoma: pictorial review". Iran J Radiol. 8 (3): 182–9. doi:10.5812/kmp.iranjradiol.17351065.3392. PMC 3522328. PMID 23329939.
- ↑ Atesok KI, Alman BA, Schemitsch EH, Peyser A, Mankin H (2011). "Osteoid osteoma and osteoblastoma". J Am Acad Orthop Surg. 19 (11): 678–89. PMID 22052644.
- ↑ Lee EH, Shafi M, Hui JH (2006). "Osteoid osteoma: a current review". J Pediatr Orthop. 26 (5): 695–700. doi:10.1097/01.bpo.0000233807.80046.7c. PMID 16932114.
- ↑ Kalil RK, Antunes JS (2003). "Familial occurrence of osteoid osteoma". Skeletal Radiol. 32 (7): 416–9. doi:10.1007/s00256-003-0660-y. PMID 12802523.
- ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.
- ↑ 18.0 18.1 18.2 Barlow E, Davies AM, Cool WP, Barlow D, Mangham DC (2013). "Osteoid osteoma and osteoblastoma: novel histological and immunohistochemical observations as evidence for a single entity". J Clin Pathol. 66 (9): 768–74. doi:10.1136/jclinpath-2013-201492. PMID 23814261.
- ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.
- ↑ Rand JA, Sim FH, Unni KK (1982). "Two osteoid-osteomas in one patient. A case report". J Bone Joint Surg Am. 64 (8): 1243. PMID 7130236.
- ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.
- ↑ Greenspan A (1993). "Benign bone-forming lesions: osteoma, osteoid osteoma, and osteoblastoma. Clinical, imaging, pathologic, and differential considerations". Skeletal Radiol. 22 (7): 485–500. PMID 8272884.